Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices ...

This was the stock's third consecutive day of gains.

Hybrid closed-loop systems outperformed other types of subcutaneous insulin treatment for diabetes, but some systems were more efficient than others, according to results published in ...

He succeeds Karen Parkhill, the CFO since 2016 who officially ended her tenure on Aug. 2 to join the tech giant HP as finance ...

Medtronic hired a new chief financial officer away from French carmaker Renault. Thierry Pieton, chief financial officer of ...

The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Medtronic has been integrating AI capabilities ... In diabetes care, the MiniMed 780G insulin pump system uses AI algorithms to predict and adjust insulin delivery based on real-time blood sugar ...

See the 10 stocks » Medtronic (NYSE: MDT ... In diabetes care, the MiniMed 780G insulin pump system uses AI algorithms to predict and adjust insulin delivery based on real-time blood sugar ...

Growth prospects remain bright. As type 1 and type 2 diabetes continue inflicting people, Medtronic's solutions such as MiniMed (insulin pump), InPen (real-time continuous glucose monitoring and ...

The University of Minnesota and Medtronic have entered into a new strategic collaboration to address “meaningful and difficult healthcare challenges.” Medtronic and the University of Minnesota said ...